Nonhuman Primate Welfare 2023
DOI: 10.1007/978-3-030-82708-3_16
|View full text |Cite
|
Sign up to set email alerts
|

Humane Endpoints and End of Life in Primates Used in Laboratories

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 31 publications
0
1
0
Order By: Relevance
“…Severity (Supplementary Table 3) was determined by the extent and distribution of inflammation, vascular change (infarction, thrombosis, pregnancy-associated vascular remodeling and/or the lack thereof), and non-vascular necrosis across the tissue section or organ (multiple slides were necessary to evaluate the placenta). Scores were averaged and compared between treatment groups as previously reported [24].…”
Section: Histologymentioning
confidence: 99%
“…Severity (Supplementary Table 3) was determined by the extent and distribution of inflammation, vascular change (infarction, thrombosis, pregnancy-associated vascular remodeling and/or the lack thereof), and non-vascular necrosis across the tissue section or organ (multiple slides were necessary to evaluate the placenta). Scores were averaged and compared between treatment groups as previously reported [24].…”
Section: Histologymentioning
confidence: 99%
“…The copyright holder for this preprint this version posted June 19, 2023. ; https://doi.org/10.1101/2023.06.18.545418 doi: bioRxiv preprint distribution of inflammation, vascular change (infarction, thrombosis, pregnancy-associated vascular remodeling and/or the lack thereof), and non-vascular necrosis across the tissue section or organ (multiple slides were necessary to evaluate the placenta). Scores were averaged and compared between treatment groups as previously reported [24].…”
Section: Histologymentioning
confidence: 99%